Medtronic Minimed Inc. v. Animas Corp.

ORDER RE: DEFENDANT’S MOTION FOR PARTIAL SUMMARY JUDGMENT OF INVALIDITY OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 5,665,065 [69]

Currently before the Court is Defendant Animas Corporation’s (“Defendant”) Motion for Partial Summary Judgment of Invalidity of the Asserted Claims of U.S. Patent No. 5,665,065 [69], Plaintiffs Med-tronic Minimed Inc., Medtronic Puerto Rico Operations ’ Co., and Minimed Distribution Corp. (collectively, “Plaintiffs”), filed their Opposition on February 6, 2014 [83]. Defendant filed its Reply on February 18, 2014 [90]. The Court heard arguments on this matter on April 16, 2014 [103]. The Court, having reviewed all papers and arguments submitted pertaining to this Motion, NOW FINDS AND RULES AS FOLLOWS: The Court DENIES Defendant’s Motion.

I. BACKGROUND

Plaintiffs design, manufacture, and distribute portable insulin delivery systems for use by individuals with diabetes. In relation thereto, Plaintiff Medtronic Min-iMed Inc. owns eight separate United States patents, all of which are titled “External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities.” First Am. Compl. (“FAC”) ¶¶ 10, 15, 20, 25, 30, 36, 41, 48.…